Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor

被引:83
作者
Gmyrek, GA
Walburg, M
Webb, CP
Yu, HM
You, XK
Vaughan, ED
Woude, GFV
Knudsen, BS
机构
[1] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Urol, New York, NY 10021 USA
[3] New York Presbyterian Hosp, New York, NY USA
[4] Van Andel Res Inst, Grand Rapids, MI USA
关键词
D O I
10.1016/S0002-9440(10)61729-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hepatocyte growth factor/scatter factor (HGF/SF) promotes the proliferation, differentiation, motility, and invasion of epithelial cells by binding to its cell. surface receptor, the Met tyrosine kinase. In the prostate, Met is expressed predominantly by prostate epithelial cells (PrEC), whereas HGF/SF is synthesized by prostate stromal cells (PrSC). Met is also expressed in localized and metastatic prostate cancers. Our results show that PrECs in hi vitro culture maintain expression of Met at a level comparable to DU145 cancer cell expression. HGF/SF secreted by PrSC stimulates tyrosine phosphorylation of the Met receptor. In normal PrEC, HGF/SF causes growth inhibition, sustained phosphorylation of mitogen-activated protein kinase, and increased CK18 expression consistent with cell differentiation. in contrast, HGF/SF significantly stimulates the proliferation of DU145 prostate cancer cells. HGF/SF in the conditioned medium of PrSC specifically induces migration of both normal and malignant prostate epithelial cells through MatriGel-coated Transwell filters. HGF/SF depletion reduces cell migration by approximately 50%. The response of PrEC is specific for HGF/SF since the other growth factors tested do not significantly affect growth or migration of PrECs. These results support the in vivo importance of the prostate stroma and specifically of HGF/SF as a unique stromal derived factor in the development and progression of prostate cancer.
引用
收藏
页码:579 / 590
页数:12
相关论文
共 80 条
  • [1] KERATINOCYTE GROWTH-FACTOR FUNCTIONS IN EPITHELIAL INDUCTION DURING SEMINAL-VESICLE DEVELOPMENT
    ALARID, ET
    RUBIN, JS
    YOUNG, P
    CHEDID, M
    RON, D
    AARONSON, SA
    CUNHA, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (03) : 1074 - 1078
  • [2] BELLUSCI S, 1994, ONCOGENE, V9, P1091
  • [3] ESSENTIAL ROLE FOR THE C-MET RECEPTOR IN THE MIGRATION OF MYOGENIC PRECURSOR CELLS INTO THE LIMB BUD
    BLADT, F
    RIETHMACHER, D
    ISENMANN, S
    AGUZZI, A
    BIRCHMEIER, C
    [J]. NATURE, 1995, 376 (6543) : 768 - 771
  • [4] Condon MS, 1999, IN VIVO, V13, P61
  • [5] MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE
    COOPER, CS
    PARK, M
    BLAIR, DG
    TAINSKY, MA
    HUEBNER, K
    CROCE, CM
    VANDEWOUDE, GF
    [J]. NATURE, 1984, 311 (5981) : 29 - 33
  • [6] CUNHA GR, 1994, CANCER, V74, P1030, DOI 10.1002/1097-0142(19940801)74:3+<1030::AID-CNCR2820741510>3.0.CO
  • [7] 2-Q
  • [8] Proliferative inflammatory atrophy of the prostate - Implications for prostatic carcinogenesis
    De Marzo, AM
    Marchi, VL
    Epstein, JI
    Nelson, WG
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) : 1985 - 1992
  • [9] Prostate stem cell compartments -: Expression of the cell cycle inhibitor p27Kip1 in, normal, hyperplastic, and neoplastic cells
    De Marzo, AM
    Meeker, AK
    Epstein, JI
    Coffey, DS
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) : 911 - 919
  • [10] Donjacour A A, 1991, Cancer Treat Res, V53, P335